Arm Holdings CEO Rene Haas told the BBC in an interview on September 7, 2026 that AI could help cure cancer by simulating how the disease interacts with DNA. However, he stated that the required biological modeling is too complex for current AI systems, a limitation driven by a semiconductor industry he described as absolutely supply-constrained. Arm, whose technology powers over 350 billion chips shipped worldwide, launched its AGI CPU in March 2026, designed for AI-optimized workloads. Haas, who stepped down from AstraZeneca’s board in April 2026, remains confident that a cure could come within our lifetime.
Source: Read the original article
